跳至主要内容
临床试验/NCT05408676
NCT05408676已完成不适用

Comparison of Dexamethasone Alone vs in Combination With Pericardium 6 (P6) Electrical Stimulation or Granisetron in the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Breast Cancer Surgery

Fudan University1 个研究点 分布在 1 个国家目标入组 198 人开始时间: 2022年6月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
198
试验地点
1
主要终点
PONV within the first 24h after surgery

研究概览

简要总结

Breast cancer is one of the three most common cancers worldwide, and the primary treatment method is surgery.Since most patients are non-smokers who use opioids in the postoperative period, which are known risk factors for postoperative nausea and vomiting (PONV) according to the Apfel Risk Score. Breast surgery was identified as a strong risk factor for PONV. According to the previous studies, the incidence of PONV is 30-70% in patients undergoing the breast cancer surgery, which not only gives patients unpleasant and painful experience, but also prolongs the hospital stays and delay patient discharge and adds to hospital costs. We compared the effects of dexamethasone alone vs. in combination with Pericardium 6 (P6) electrical stimulation or granisetron for inhibition of PONV in women undergoing breast cancer surgery.

详细描述

186 patients who are planed to undergo elective breast cancer surgery under general anaesthesia into the following three groups: acupoint stimulation+dexamethasone (Group Acu, n=62), granisetron +dexamethasone (Group Gra, n=62), and dexamethasone alone (Group Dxm, n=62). The incidence of nausea, vomiting, and need for rescue antiemetics was recorded 2, 6, 24, and 48 h after surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • women undergoing breast cancer resection under general anesthesia
  • aged between 18 to 65
  • American Society of Anesthesiologists grade I-II

排除标准

  • using antiemetic drugs within 24 h before operation,
  • nausea or vomiting within 24 h before operation;
  • Alcoholic or drug abuse,
  • abnormal liver and/or kidney function, diabetic or peripheral neuropathy patients, cardiovascular disease (excluding those with controlled hypertension).
  • refuse to participate clinical trial

结局指标

主要结局

PONV within the first 24h after surgery

时间窗: 24 hours after surgery.

the incidence and severity of PONV

次要结局

  • the use of postoperative antiemetics(48 hours after surgery)
  • PONV within the first 48h after surgery(48 hours after surgery)
  • postoperative pain score(3 months after surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jun Zhang

Professor

Fudan University

研究点 (1)

Loading locations...

相似试验